As we prepare for our European Commercial Launch, it is important to stay focused and healthy. Change Starts Within at #MorphicMedical. Morphic Medicals company Fun Run is a good place to start. Joseph Virgilio Steve Linhares Don Keren Mike Gutteridge Chris Thierfelder Eva Weinstein Pranaya Jukanti Prey Patel Erin Doyle #RESET #diabetes #obesity
About us
Morphic Medical (formerly GI Dynamics Inc.) is the developer of RESET® (EndoBarrier), an endoscopically delivered device therapy that offers a non-surgical, alternative treatment for the treatment of type 2 diabetes and obesity. RESET is not approved for sale in the United States and is limited by federal law to investigational use only. Founded in 2003, Morphic Medical is headquartered in Boston, Massachusetts.
- Website
-
https://morphicmedical.com
External link for Morphic Medical
- Industry
- Medical Device
- Company size
- 11-50 employees
- Headquarters
- Boston, Massachusetts
- Type
- Privately Held
- Founded
- 2003
- Specialties
- Medical Device, Type 2 Diabetes, and Obesity
Locations
-
Primary
355 Congress St.
Boston, Massachusetts 02210, US
-
Prinzenallee 7
Dusseldorf, 40549, DE
-
Employees at Morphic Medical
Updates
-
Learn more about the #RESET (F/K/A EndoBarrier) treatment for #Type2Diabetes and #Obesity at Dr. Bob Ryder’s poster session at the upcoming American Diabetes Association’s 84th Scientific Sessions (#ADA) taking place in Orlando, FL. He will be available for discussion on June 24 12:30pm during the General Poster Session. https://lnkd.in/eVRVVgG #diabetes #MorphicMedical
-
-
Planning your time at Digestive Disease Week taking place in Washington D.C. May 19-21? If you would like to learn about #MorphicMedical's most recent developments with #RESET, please reach out to us to set up an in-person meeting by contacting us at info@morphicmedical.com. #endoscopy #bariatric #diabetes #obesity #gastroentrology #DDW2024 https://ddw.org/
-
NEWS ALERT! Read the latest article on #RESET (F/K/A #EndoBarrier), the world’s first medical device designed to target the underlying cause of metabolic disorders including #Type2diabetes and #obesity. “With RESET, we are trying to bridge the gap between pharmaceuticals and surgery and provide an alternate treatment option to help reduce HbA1c and weight for individuals who are underserved by drugs and insulin injections, but for whom surgery may not be an option,” according to Joseph Virgilio, President and & CEO of Morphic Medical. “This latest research highlights the potential clinical benefits of RESET which offers an alternative way to help treat or manage patients with uncontrolled type 2 diabetes and obesity.” Click the link below to read all about it! https://lnkd.in/gSzjpKXm
Temporary 'gut liner' which makes patients feel full more quickly
dailymail.co.uk
-
#MorphicMedical is looking forward to IFSO-EC 2024 in Vienna May 2-4! IFSO will be a great opportunity to learn about the latest advancements in endoscopic procedures including Morphic Medical’s most recent developments with #RESET. Reach out to set up an in-person meeting. #endoscopy #bariatric #diabetes #obesity https://lnkd.in/eAvWa6GV
-
-
Dr. Ryder’s poster highlighting two-year outcomes following RESET (F/K/A EndoBarrier) treatment for Type 2 Diabetes and #Obesity will be on view during Diabetes UK taking place April 17-19. Join him for discussion on April 18 during the New technology, Therapies and Treatment Poster Session. https://lnkd.in/dFka_8J #diabetes #MorphicMedical #RESET
-
-
We are pleased to announce Joseph Virgilio, our President and CEO, will join a panel of industry leaders at the upcoming MedTech Impact Symposium to discuss #diabetes interventions. The session will examine the evolution of diabetes care and how medical technology has improved the management and monitoring of the condition. https://lnkd.in/e997JQ8Z #medtechimpact #medtech
-
-
Morphic Medical reposted this
#MorphicMedical is excited to support the Medtech Impact Symposium & Gala on March 28, 2024 at the Encore Boston Harbor in Everett, MA. The Symposium brings together diverse industry stakeholders to discuss the impact medical technology has on improving healthcare outcomes. Focusing on the technologies poised to shape the medtech industry, our day-long conversations will encompass topics such as the use of data and AI to improve medical technology and personalize medicine. The event will also take a deep dive into the impact of medical technology on care within four distinct areas: Maternal Health, Cardiac Health, Diabetes, and Musculoskeletal Health. In the evening of March 28, @MassMEDIC also hosts their Annual Medtech Impact Gala. This black-tie optional Gala is the premier medtech event that celebrates the impact of our industry’s work on patients’ lives. Join us at this great event! https://lnkd.in/e997JQ8Z #medtechimpact #medtech #maternalhealth #cardiachealth #mskhealth #diabetes #ai #percisionmedicine #heartofhealthtech
-
-
#MorphicMedical is excited to support the Medtech Impact Symposium & Gala on March 28, 2024 at the Encore Boston Harbor in Everett, MA. The Symposium brings together diverse industry stakeholders to discuss the impact medical technology has on improving healthcare outcomes. Focusing on the technologies poised to shape the medtech industry, our day-long conversations will encompass topics such as the use of data and AI to improve medical technology and personalize medicine. The event will also take a deep dive into the impact of medical technology on care within four distinct areas: Maternal Health, Cardiac Health, Diabetes, and Musculoskeletal Health. In the evening of March 28, @MassMEDIC also hosts their Annual Medtech Impact Gala. This black-tie optional Gala is the premier medtech event that celebrates the impact of our industry’s work on patients’ lives. Join us at this great event! https://lnkd.in/e997JQ8Z #medtechimpact #medtech #maternalhealth #cardiachealth #mskhealth #diabetes #ai #percisionmedicine #heartofhealthtech
-
-
On World Obesity Day, it is important to recognize the increasing trend in #obesity and its link to a range of diseases, including heart disease, stroke, #diabetes, and various types of cancer. At #morphicmedical, we are committed to addressing this disease with the development of the world’s first medical device designed to target the underlying cause of metabolic disorders including #T2D and obesity. Follow Morphic Medical to find out more.
-